Physician profile
Paul Vb Hyde
NPI 1225056906
$552.43
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $151 · 2021: $115 · 2022: $112 · 2023: $62.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $109.77 | 2019-2022 | |
| Allergan, INC. | $108.64 | 2019-2022 | |
| Tela Bio, INC. | $93.63 | 2019-2022 | |
| Elucent Medical | $62.30 | 2023 | |
| Davol INC. | $44.07 | 2019 | |
| Myriad Genetic Laboratories, INC. | $25.79 | 2022 | |
| Innocoll Pharmaceuticals Limited | $24.40 | 2021 | |
| Aroa Biosurgery Incorporated | $23.00 | 2022 | |
| Cardinal Health 200 LLC | $17.74 | 2021 | |
| Apollo Endosurgery US INC | $15.79 | 2021 | |
| Baxter Healthcare | $14.49 | 2019 | |
| Covidien LP | $12.81 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.